{"gene":"ALDH1A2","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":1997,"finding":"RALDH2 (ALDH1A2) was identified as a major retinoic acid (RA)-generating enzyme in the early mouse embryo; its expression in mesoderm marks sites of endogenous RA synthesis, and exogenous RA administration downregulates RALDH2 transcript levels, suggesting a negative feedback mechanism on RA synthesis.","method":"In situ hybridization, RA administration experiments in mouse embryos","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated across multiple labs with orthogonal methods; foundational study establishing enzymatic identity and negative feedback","pmids":["9106168"],"is_preprint":false},{"year":2002,"finding":"Kinetic analysis of purified recombinant mouse RALDH2 demonstrated that it catalyzes oxidation of retinal to retinoic acid with a pH optimum of 9.0, with highest catalytic efficiency for all-trans retinal (Km ~0.66 µM) compared to 9-cis retinal (Km ~2.25 µM); the enzyme is inhibited by citral and p-HMB, and activated by MgCl2.","method":"In vitro enzyme kinetics using purified recombinant RALDH2","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro enzymatic characterization with purified recombinant protein and multiple substrate/inhibitor conditions","pmids":["11983430"],"is_preprint":false},{"year":1999,"finding":"Injection of mouse Raldh2 mRNA into Xenopus embryos stimulates RA synthesis at high levels in vivo, whereas ALDH3 mRNA injection produces no detectable RA synthesis, establishing Raldh2 as a genuine RA-synthesizing enzyme in vivo. Immunohistochemistry showed RALDH2 protein is localized primarily in trunk tissues (paraxial mesoderm, somites, pericardium, midgut, mesonephros) at E7.5–E10.5.","method":"Xenopus mRNA injection with RA activity assay; whole-mount immunohistochemistry in mouse embryos","journal":"Developmental genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vivo functional assay combined with immunolocalization, replicated concept across labs","pmids":["10570467"],"is_preprint":false},{"year":2002,"finding":"Targeted disruption of Raldh2 in mice arrests development at midgestation and eliminates nearly all RA synthesis in the embryo (except RALDH3-dependent activity in the surface ectoderm of the eye field), demonstrating that RALDH2 is responsible for most embryonic RA synthesis. Conditional rescue by limited maternal RA revealed additional RA-generating activities in the neural tube and heart not corresponding to Raldh1–3.","method":"Raldh2 knockout mice, RA-responsive transgene reporter, maternal RA rescue","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic null with RA reporter and rescue experiment; replicated finding across multiple papers","pmids":["11959834"],"is_preprint":false},{"year":2001,"finding":"The zebrafish neckless mutation inactivates Raldh2, causing truncation of the anteroposterior axis, midline mesendodermal defects, and absence of pectoral fins. Mosaic analysis showed that reduced hoxb4 expression in the nervous system is non-cell-autonomous, reflecting a requirement for RA signaling from adjacent paraxial mesoderm.","method":"Zebrafish forward genetics, mosaic analysis, RA rescue experiment","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with mosaic analysis and RA rescue; establishes non-cell-autonomous mesoderm-to-neural signaling role","pmids":["11688558"],"is_preprint":false},{"year":2003,"finding":"Raldh2 is the enzyme responsible for RA synthesis in the posterior pharyngeal mesoderm; its inactivation (with early rescue) causes failure of posterior pharyngeal pouch formation, impaired neural crest migration, and agenesis of enteric ganglia resembling Hirschsprung's disease, establishing RALDH2-generated RA as a mesodermal signal patterning pharyngeal endoderm.","method":"Raldh2 conditional knockout mice (RA-rescued), in situ hybridization, in vivo phenotype analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic null with conditional rescue and mechanistic pathway placement","pmids":["12702665"],"is_preprint":false},{"year":2005,"finding":"Raldh2 expressed in dorsal pancreatic mesenchyme provides RA signal to dorsal endoderm required for Pdx1 and Isl1 expression and dorsal pancreatic bud formation; Raldh2−/− embryos specifically lack dorsal but not ventral pancreatic development, and maternal RA supplementation rescues these defects.","method":"Raldh2 knockout mice, in situ hybridization, RA reporter transgene, maternal RA rescue","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods in knockout with rescue, replicated across two independent studies (PMIDs 16026781 and 15739227)","pmids":["16026781","15739227"],"is_preprint":false},{"year":2004,"finding":"Raldh2 in the optic vesicle generates a RA signal required for retina invagination and optic cup formation; Raldh2−/− embryos fail to develop an optic cup, and maternal RA administration rescues this defect. RALDH3 activity in the lens placode is insufficient to substitute.","method":"Raldh2 knockout and Raldh1/Raldh2 double-knockout mice, RA reporter, maternal RA rescue","journal":"Developmental dynamics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic nulls with rescue and epistatic comparison of multiple Raldh family members","pmids":["15366004"],"is_preprint":false},{"year":2004,"finding":"Raldh2 in lateral plate mesoderm controls two phases of RA signaling for limb development: an early phase (E8) upstream of Tbx5, Meis2, and dHand for forelimb bud initiation, and a late phase providing a proximodistal RA gradient for AER expansion. Raldh2−/− embryos fail to initiate forelimbs; selective RA rescue at E8 restores initiation but not full AER formation.","method":"Raldh2 knockout mice, RA reporter transgene, timed maternal RA administration, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic null with temporally controlled rescue establishing two distinct signaling phases","pmids":["15069081"],"is_preprint":false},{"year":2005,"finding":"Raldh2 in somitic mesoderm is required for posterior neural transformation (spinal cord fate specification); Raldh2−/− embryos show loss of Pax6 and Olig2 in posterior neural plate, and RA generated by Raldh2 acts directly in neuroectoderm (not somitic mesoderm) to promote spinal cord differentiation while also suppressing Fgf8 in the tailbud.","method":"Raldh2 knockout mice, in situ hybridization, RA reporter transgene, maternal RA rescue","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic null with RA reporter distinguishing cell-autonomous vs. non-cell-autonomous action","pmids":["15652703"],"is_preprint":false},{"year":2005,"finding":"Transfection-mediated re-expression of wild-type ALDH1A2 (but not a presumptive catalytically dead mutant) in the prostate cancer cell line DU145 decreased colony growth, demonstrating that ALDH1A2 tumor-suppressive activity depends on its enzymatic (RA-synthesizing) function.","method":"Transfection of wild-type vs. catalytic mutant ALDH1A2 in DU145 cells, colony formation assay","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, catalytic mutant experiment establishing enzymatic requirement, but limited characterization of mutant","pmids":["16166285"],"is_preprint":false},{"year":2011,"finding":"ALDH1A2 and ALDH2 enzymatic activity is detected by the Aldefluor assay; DEAB inhibits both isoenzymes (65–90% reduction), demonstrating that DEAB is not specific for ALDH1A1. Overexpression of ALDH1A2 in K562 and H1299 cells increased cell proliferation, clonal efficiency, and resistance to 4-hydroperoxycyclophosphamide and doxorubicin.","method":"Lentiviral overexpression, activity assay, Aldefluor flow cytometry, DEAB inhibition, Western blot","journal":"Chemico-biological interactions","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional overexpression with enzymatic activity measurements and pharmacological inhibition, single lab","pmids":["22079344"],"is_preprint":false},{"year":2011,"finding":"WT1 (Wilms Tumor 1) transcription factor directly activates Raldh2 transcription in epicardial cells; Wt1-null epicardial cells display decreased Raldh2 expression and reduced RA synthesis. WT1 was shown to be a direct transcriptional activator of Raldh2, and PDGFRα expression (but not RXRα) is rescued by RA addition to Wt1-null cells.","method":"In vivo and in vitro Wt1 knockout epicardial cells, RA-responsive reporter, ChIP (implied by 'direct transcriptional target' statement), rescue experiments","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with functional RA reporter and direct transcriptional target demonstration, single lab","pmids":["21343363"],"is_preprint":false},{"year":2018,"finding":"X-ray crystal structures of human ALDH1A2 in complex with irreversible inhibitor WIN18,446 revealed that WIN18,446 covalently modifies the catalytic residue Cys320, forming a chiral adduct in (R) configuration that distorts the neighboring NAD cofactor into a contracted conformation suboptimal for the dehydrogenase reaction. Reversible inhibitors interact via hydrogen bonds near Cys320 without affecting NAD. A large flexible loop becomes ordered upon inhibitor binding, shielding the active site.","method":"X-ray crystallography, direct binding studies","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures with mechanistic interpretation; direct binding studies; single lab but multiple inhibitor chemotypes and rigorous structural analysis","pmids":["29240402"],"is_preprint":false},{"year":2009,"finding":"Mutations Ala151Ser and Ile157Thr in the ALDH1A2 tetramerization domain (exon 4) found in Tetralogy of Fallot patients were shown by molecular mechanics simulation to hinder tetramerization of the enzyme, suggesting loss of functional oligomeric assembly as a disease mechanism.","method":"Sequencing of CHD patients, molecular mechanics simulation (AMBER 9), phylogenetic conservation analysis","journal":"BMC medical genetics","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational modeling only, no direct biochemical validation of impaired tetramerization in vitro","pmids":["19886994"],"is_preprint":false},{"year":2014,"finding":"GM-CSF-induced RALDH2 expression in dendritic cells requires cooperative binding of the transcription factor Sp1 (activated via ERK and p38 MAPK) and the RAR/RXR complex (specifically RARα/RXRα) to the Aldh1a2 promoter; Sp1 binds GC-rich sites and RAR/RXR binds an RA response element (RARE) half-site near the TATA box. Inhibition of either Sp1 or RAR blocked GM-CSF-induced Aldh1a2 expression.","method":"Chromatin immunoprecipitation (ChIP), promoter-reporter luciferase assay, EMSA, pharmacological inhibitors, siRNA knockdown","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (ChIP, EMSA, luciferase, siRNA) in single lab establishing direct promoter mechanism","pmids":["24788806"],"is_preprint":false},{"year":2017,"finding":"Notch signaling (via RBPJ) directly regulates Aldh1a2 transcription in dendritic cells; RBPJ protein binds the Aldh1a2 promoter and its deficiency reduces RALDH2 expression, shifting DC function from iTreg induction toward Th17 promotion. Overexpression of Aldh1a2 in RBPJ-deficient DCs rescued iTreg-promoting ability.","method":"DC-specific Rbpj knockout mice, ChIP, Aldh1a2 overexpression rescue, in vivo colitis model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct promoter binding, genetic KO with rescue, functional in vivo validation","pmids":["28779023"],"is_preprint":false},{"year":2018,"finding":"PU.1 and IRF4 are transcriptional activators of the Aldh1a2 gene in dendritic cells; they form a heterodimer that binds an EICE motif at −1961/−1952 of the Aldh1a2 promoter. Knockdown of Spi1 (PU.1) or Irf4 reduced Aldh1a2 mRNA and RALDH2 enzyme activity; this binding was validated in freshly isolated splenic and mesenteric DCs.","method":"ChIP, reporter assay, EMSA, siRNA knockdown in BMDCs and primary DCs","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (ChIP, EMSA, reporter, siRNA) in vitro and ex vivo","pmids":["30413670"],"is_preprint":false},{"year":2013,"finding":"RALDH2 is a required component of PPARγ-directed all-trans retinoic acid (ATRA) synthesis in dendritic cells; RDH10, RALDH2, and CRABP2 form a linear pathway downstream of PPARγ activation for ATRA production. Only DC subsets expressing all three proteins produce ATRA efficiently.","method":"Gene expression analysis, PPARγ activation, functional ATRA production assay in DC subsets","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional pathway validation in specific DC subsets, multiple proteins tested, single lab","pmids":["23833249"],"is_preprint":false},{"year":2021,"finding":"Tbx5 transcription factor directly maintains aldh1a2 expression in foregut lateral plate mesoderm via an evolutionarily conserved intronic enhancer, establishing a Tbx5→Aldh1a2→RA→Shh→Wnt signaling cascade coordinating cardiopulmonary development. This was demonstrated in both Xenopus and mouse embryos.","method":"Xenopus and mouse embryo experiments, enhancer reporter assays, genetic epistasis, in situ hybridization","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct enhancer validation, two model organisms, genetic epistasis establishing pathway order","pmids":["34643182"],"is_preprint":false},{"year":2015,"finding":"Foxc1a transcription factor directly binds the aldh1a2 promoter and restricts its expression in paraxial mesoderm; in foxc1a knockout zebrafish, aldh1a2 expression is significantly increased, elevating RA levels and reducing myod1 expression by suppressing fgf8a and deltaC. Knockdown of aldh1a2 in foxc1a nulls partially rescues myod1 expression.","method":"TALEN-mediated foxc1a knockout zebrafish, chromatin immunoprecipitation (ChIP) on zebrafish embryos, aldh1a2 morpholino knockdown, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP directly demonstrating foxc1a binding to aldh1a2 promoter, genetic null with epistasis rescue experiments","pmids":["25724646"],"is_preprint":false},{"year":2013,"finding":"HOXA13 directly regulates Aldh1a2 expression by binding a conserved cis-regulatory element in the Aldh1a2 locus; in Hoxa13 mutant mice, Aldh1a2 expression, RA signaling, and interdigital programmed cell death are reduced. Maternal RA supplementation partially rescues digit separation defects.","method":"Hoxa13 knockout mice, ChIP (HOXA13 binding to Aldh1a2 locus), RA reporter, maternal RA rescue","journal":"Developmental dynamics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct cis-regulatory binding, genetic null with RA rescue","pmids":["23553814"],"is_preprint":false},{"year":2020,"finding":"Wnt/β-catenin signaling directly represses ALDH1A2 expression in fetal kidney (WiT49) cells; β-catenin is recruited to the ALDH1A2 promoter and intron 1 (intron1G enhancer element) as shown by ChIP, and luciferase assays confirmed these elements mediate repression. Ectopic Wnt1, Wnt3a, Wnt4, and Wnt9b all repressed ALDH1A2, and this effect required β-catenin.","method":"ChIP, luciferase reporter assay, Wnt overexpression, β-catenin inhibition, immunohistochemistry in rat kidney","journal":"Frontiers in cell and developmental biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (ChIP, luciferase, genetic, IHC), single lab","pmids":["32258025"],"is_preprint":false},{"year":2009,"finding":"Aldh1a2 is the primary aldehyde dehydrogenase acting during pancreas development in zebrafish; a null allele (glycine-to-arginine change in the catalytic domain) produces a similar but less severe phenotype than the DEAB inhibitor treatment, revealing that maternal Aldh1a2 activity persists in zygotic null embryos. Translation-blocking (but not splice-blocking) morpholinos phenocopy DEAB treatment, confirming maternal protein contribution.","method":"Zebrafish forward genetics, morpholino knockdown, DEAB pharmacological inhibition, gene expression analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple approaches (null mutant, morpholino, inhibitor) establishing Aldh1a2 as primary enzyme with maternal contribution","pmids":["20011517"],"is_preprint":false},{"year":2009,"finding":"Comparative regeneration analysis identified raldh2 as one of the most highly induced genes across adult caudal fin, adult heart, and larval fin regeneration in zebrafish; loss-of-function studies showed raldh2 expression is critical for wound epithelium and blastema formation. raldh2 expression during regeneration is regulated by Wnt and FGF/ERK signaling.","method":"Comparative microarray, in situ hybridization, functional loss-of-function studies in zebrafish regeneration model","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional studies in three regeneration platforms with signaling pathway placement, single lab","pmids":["19801676"],"is_preprint":false},{"year":2012,"finding":"RALDH2 is the predominant retinaldehyde dehydrogenase in the chick choroid (>100-fold higher than RALDH3) and is upregulated during recovery from form-deprivation myopia, leading to increased all-trans retinoic acid synthesis. Choroid conditioned medium from recovering eyes inhibited scleral proteoglycan synthesis, suggesting RALDH2-derived RA acts as a signal for ocular growth regulation.","method":"qRT-PCR, in situ hybridization, immunohistochemistry, LC-tandem MS quantification of atRA in organ cultures, (35)SO4 incorporation assay","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct enzyme identification with quantitative RA measurement and functional scleral assay, single lab","pmids":["22323456"],"is_preprint":false},{"year":2022,"finding":"Global deletion of Aldh1a1 and Aldh1a2 in mice blocks spermatogenesis without affecting viability. Cell-specific deletion showed that RALDH2 synthesis of RA in Sertoli cells (but not germ cells) is required for the initial round of spermatogonial differentiation. ALDH1A3 activity cannot compensate for loss of both ALDH1A1 and ALDH1A2.","method":"Global and cell-specific (Sertoli cell and germ cell) Cre-loxP conditional knockout mice, histological analysis of spermatogenesis","journal":"Frontiers in endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-type-specific genetic ablation with defined cellular phenotype and negative result for compensation by ALDH1A3","pmids":["35574006"],"is_preprint":false},{"year":2021,"finding":"Biallelic hypomorphic missense variants in ALDH1A2 in two unrelated human families cause a lethal multiple congenital anomaly syndrome (diaphragmatic, pulmonary, cardiovascular defects). In vitro studies of the variants showed reduced RA production, and in silico modeling indicated probable impairment of ALDH1A2 function for three of four substitutions.","method":"Exome sequencing, in vitro RA synthesis assay, in silico protein modeling","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro functional validation of RA reduction, but structural modeling is computational; two independent families strengthen human disease link","pmids":["33565183"],"is_preprint":false},{"year":2020,"finding":"In intestinal CD11b−CD103+ dendritic cells, CD137 engagement activates TAK1 and the AMPK-PGC-1α axis, which enhances Aldh1a2 transcription and RALDH2 expression. RALDH2-derived RA then acts on adjacent CD11b+CD103− DCs to induce SOCS3, suppressing p38MAPK and IL-23 production, defining a paracrine immunoregulatory circuit.","method":"DC-specific CD137 knockout mice, pathway inhibitors, RA administration rescue, gene expression analysis, in vivo colitis model","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with pathway dissection and rescue, single lab","pmids":["32209473"],"is_preprint":false},{"year":2018,"finding":"ALDH1A2 depletion by RNA interference in primary human chondrocytes altered expression of chondrogenic markers including SOX9, establishing a functional role for ALDH1A2 in chondrocyte biology. The OA-risk allele rs12915901 is associated with reduced ALDH1A2 expression in cartilage through allelic expression imbalance, with Ets transcription factors identified as potential mediators.","method":"RNAi knockdown in primary human chondrocytes, allelic expression imbalance by pyrosequencing, in silico and in vitro analysis of SNP function","journal":"Arthritis & rheumatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi knockdown with gene expression phenotype, allelic imbalance confirmed in patient tissues, single lab","pmids":["29732726"],"is_preprint":false},{"year":2022,"finding":"Cartilage injury upregulates inflammatory genes (mechanoflammation) with concomitant reduction of atRA-inducible genes; talarozole (a RAMBA that blocks RA catabolism, thereby boosting atRA) reverses both responses via a PPARγ-dependent mechanism. Talarozole suppressed mechano-inflammatory genes in articular cartilage in vivo 6 hours after joint destabilization and reduced cartilage degradation and osteophyte formation after 26 days in mice.","method":"RNA sequencing of human OA cartilage stratified by genotype, cartilage injury model, talarozole treatment in vitro and in vivo, PPARγ pathway analysis","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — human tissue stratified by genotype + in vitro mechanism + in vivo mouse validation with defined pathway (PPARγ)","pmids":["36542696"],"is_preprint":false},{"year":2023,"finding":"Aldh1a2+ fibroblastic reticular cells (FRCs) in omental milky spots regulate lymphocyte recruitment by controlling CXCL12 display on high endothelial venules (HEVs). Diphtheria toxin-mediated ablation of Aldh1a2+ FRCs reduced milky spot size and cellularity and altered peritoneal lymphocyte composition.","method":"Cell-specific diphtheria toxin ablation (Aldh1a2-DTR mouse), flow cytometry, immunofluorescence, CXCL12 expression analysis","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — selective cell ablation with mechanistic link to CXCL12/HEV pathway, single lab","pmids":["36880532"],"is_preprint":false},{"year":2026,"finding":"GM-CSF-IL-4-induced differentiating dendritic cells express ALDH1A2 and produce retinoic acid that inhibits DC maturation (autocrine brake). Genetic knockout of Aldh1a2 in DCs enhances DC function and antigen-specific T cell responses. A selective ALDH1A2 small-molecule inhibitor with high potency was developed and shown to improve DC vaccine efficacy.","method":"Genetic Aldh1a2 knockout in DCs, ALDH1A2 inhibitor development and testing, DC vaccine efficacy assays, antigen-specific T cell response measurement","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO + pharmacological inhibitor with orthogonal functional readouts establishing autocrine RA-mediated brake on DC maturation","pmids":["41491403"],"is_preprint":false},{"year":2025,"finding":"Identification and characterization by mass spectrometry of a WIN18,446 aldehyde metabolite (M-54) and a WIN18,446-derived protein adduct of mass 292.07 Da on Cys319 of ALDH1A2, confirming covalent modification of the active-site cysteine as the mechanism of irreversible inhibition. Analogous adducts were detected on ALDH1A1 and ALDH2 active-site cysteines in human liver samples.","method":"Mass spectrometry (proteomics), crystal structure, LC-MS/MS, human liver samples","journal":"Drug metabolism reviews","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus MS-based direct identification of covalent adduct, mechanistic extension of prior structural work","pmids":["42124481"],"is_preprint":false},{"year":2025,"finding":"First apo-ALDH1A2 crystal structure (without bound ligand/cofactor) was obtained from nanolitre sitting-drop crystallisation, expanding the structural basis for drug discovery studies on this isoform.","method":"X-ray crystallography (nanolitre sitting-drop crystallisation)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — structural determination is rigorous but no functional mutagenesis or binding studies reported in abstract","pmids":["40829477"],"is_preprint":false},{"year":2026,"finding":"Cardiomyocyte-specific ALDH1A2 ablation aggravated heart dysfunction and fibrosis after ischemia-reperfusion injury in mice, whereas ALDH1A2 overexpression provided protection. The cardioprotective mechanism depends on ALDH1A2-catalyzed RA production, which activates RA receptors to regulate Bmp7 transcription, inhibiting cell death and cardiac fibrosis.","method":"Cardiomyocyte-specific Aldh1a2 knockout and overexpression in mouse I/R model, transcriptional profiling, RA receptor pathway analysis, Bmp7 expression measurement","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic gain- and loss-of-function in vivo with defined RA→RAR→Bmp7 pathway, single lab","pmids":["41689430"],"is_preprint":false},{"year":2020,"finding":"RALDH2 mRNA is a direct post-transcriptional target of the RNA-binding protein tristetraprolin (TTP/ZFP36) in intestinal dendritic cells; Zfp36−/− mice show increased vitamin A metabolism by gut DCs and expanded colonic Treg numbers, a phenotype linked to elevated RALDH2 activity.","method":"Zfp36 knockout mice, colonic DC analysis, vitamin A metabolism assay, Treg quantification","journal":"Mucosal immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with direct statement of RALDH2 as TTP target and functional Treg readout, single lab","pmids":["32467605"],"is_preprint":false},{"year":2020,"finding":"ROBO2 binds RALDH2 as a novel binding partner in the common nephric duct (CND) and primitive bladder; loss of Robo2 impairs CND migration and fusion with the primitive bladder, delayed apoptosis, and abnormal ureter connection. Retinoic acid administration rescued ureter anomalies in Robo2−/− embryos, establishing a ROBO2-RALDH2-RA pathway in ureter development.","method":"Robo2 knockout mice, Co-IP (ROBO2-RALDH2 interaction), in situ hybridization, RA rescue experiment","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — binding partner identification by Co-IP, genetic null with RA rescue, single lab","pmids":["32562756"],"is_preprint":false},{"year":2024,"finding":"Non-canonical NF-κB signaling (RelB:p52) in intestinal DCs activates Axin1 transcription, thereby destabilizing β-catenin and reducing β-catenin-dependent Raldh2 expression, which suppresses tolerogenic DC function. DC-specific inactivation of non-canonical NF-κB signaling reinforces β-catenin→Raldh2 axis and increases colonic Tregs and IgA+ B cells. β-catenin haploinsufficiency in DCs lacking non-canonical NF-κB reinstates colitogenic sensitivity.","method":"DC-specific RelB knockout mice, β-catenin haploinsufficiency mouse model, genetic epistasis, transcription analysis, colitis model","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple genetic models establishing pathway order (RelB:p52→Axin1→β-catenin→Raldh2), epistasis rescue experiment, single lab","pmids":["39060515"],"is_preprint":false}],"current_model":"ALDH1A2 (RALDH2) is a NAD+-dependent aldehyde dehydrogenase that catalyzes the irreversible oxidation of retinaldehyde to all-trans retinoic acid (RA) via its active-site Cys320; it functions as a homotetramer, operates with highest catalytic efficiency for all-trans retinal, and acts as the principal embryonic RA-synthesizing enzyme in trunk mesoderm, where it generates a diffusible RA signal that patterns the nervous system, heart, pharyngeal arches, pancreas, limbs, and other organs through non-cell-autonomous mechanisms; in adult tissues it controls spermatogonial differentiation (from Sertoli cells), ocular growth, fin/heart regeneration, DC-mediated tolerogenic immune responses (regulated at the transcriptional level by WT1, Wt1/RBPJ-Notch, PU.1/IRF4, Tbx5, HOXA13, Foxc1a, and Wnt/β-catenin signaling, and post-transcriptionally by tristetraprolin), and cartilage homeostasis via suppression of mechanoflammation through a PPARγ-dependent pathway; its activity is irreversibly inhibited by covalent modification of Cys320 (e.g., by WIN18,446), and loss of enzymatic activity—whether by gene deletion, hypomorphic variants, or epigenetic silencing—underlies diverse human pathologies including congenital heart and diaphragmatic defects, osteoarthritis, and multiple cancers."},"narrative":{"mechanistic_narrative":"ALDH1A2 (RALDH2) is the principal embryonic retinoic acid (RA)-synthesizing enzyme, an NAD+-dependent retinaldehyde dehydrogenase that catalyzes oxidation of retinal to all-trans RA with highest catalytic efficiency for all-trans retinal [PMID:11983430, PMID:10570467], generating a diffusible RA signal that patterns multiple developing organs [PMID:9106168, PMID:11959834]. Its catalytic mechanism centers on an active-site cysteine (Cys320/Cys319), which irreversible inhibitors such as WIN18,446 covalently modify, distorting the bound NAD cofactor and abolishing dehydrogenase activity [PMID:29240402, PMID:42124481]. Genetic ablation eliminates nearly all embryonic RA synthesis and arrests development at midgestation [PMID:11959834], and RALDH2-derived mesodermal RA acts non-cell-autonomously to control posterior neural transformation, pharyngeal and enteric patterning, dorsal pancreatic budding, optic cup formation, limb initiation, and cardiopulmonary morphogenesis [PMID:11688558, PMID:12702665, PMID:16026781, PMID:15739227, PMID:15366004, PMID:15069081, PMID:15652703, PMID:34643182]. Its enzymatic, RA-producing function is required for its biological output, as shown by loss of activity in catalytically dead variants [PMID:16166285]. Expression is controlled by a wide regulatory network including WT1 in epicardium, Tbx5, HOXA13, and Foxc1a in developing mesoderm, Wnt/β-catenin repression, and—in dendritic cells—Sp1/RAR–RXR, RBPJ–Notch, and PU.1/IRF4, plus post-transcriptional control by tristetraprolin [PMID:21343363, PMID:34643182, PMID:25724646, PMID:23553814, PMID:32258025, PMID:24788806, PMID:28779023, PMID:30413670, PMID:32467605]. In adult physiology, RALDH2-derived RA drives spermatogonial differentiation from Sertoli cells [PMID:35574006], tolerogenic dendritic-cell programs that favor Treg induction [PMID:28779023, PMID:32209473, PMID:39060515], cardiac protection after ischemia–reperfusion via RA→RAR→Bmp7 signaling [PMID:41689430], and cartilage homeostasis through a PPARγ-dependent suppression of mechanoflammation [PMID:36542696]. Biallelic hypomorphic ALDH1A2 variants that reduce RA production cause a lethal multiple congenital anomaly syndrome with diaphragmatic, pulmonary, and cardiovascular defects [PMID:33565183], and reduced cartilage expression is linked to osteoarthritis risk [PMID:29732726].","teleology":[{"year":1997,"claim":"Established the enzymatic identity of RALDH2 as a major embryonic RA-generating enzyme and revealed RA-dependent negative feedback on its own expression.","evidence":"In situ hybridization and RA administration in mouse embryos","pmids":["9106168"],"confidence":"High","gaps":["Did not provide direct biochemical kinetics","Feedback mechanism at transcriptional level not molecularly dissected"]},{"year":1999,"claim":"Demonstrated in vivo that Raldh2 genuinely synthesizes RA and localized the protein to trunk mesodermal tissues, distinguishing it from non-RA-producing aldehyde dehydrogenases.","evidence":"Xenopus mRNA injection RA assay and whole-mount immunohistochemistry in mouse","pmids":["10570467"],"confidence":"High","gaps":["Did not establish substrate kinetics","Did not test requirement by loss-of-function"]},{"year":2002,"claim":"Defined the biochemical parameters of catalysis, confirming retinal oxidation with substrate preference and inhibitor/activator sensitivity.","evidence":"In vitro kinetics with purified recombinant mouse RALDH2","pmids":["11983430"],"confidence":"High","gaps":["Catalytic residue not yet mapped structurally","Oligomeric state not directly resolved"]},{"year":2002,"claim":"Genetic null established RALDH2 as responsible for nearly all embryonic RA synthesis and revealed residual non-Raldh1-3 RA activity in neural tube and heart.","evidence":"Raldh2 knockout mice with RA-reporter transgene and maternal RA rescue","pmids":["11959834"],"confidence":"High","gaps":["Identity of residual RA-generating activity unresolved","Tissue-specific contributions not separated"]},{"year":2001,"claim":"Showed mesoderm-derived RALDH2 RA acts non-cell-autonomously on adjacent neural tissue, defining the signaling logic of RALDH2 patterning.","evidence":"Zebrafish neckless forward genetics, mosaic analysis, RA rescue","pmids":["11688558"],"confidence":"High","gaps":["RA receptor effectors in neural tissue not defined here","Quantitative gradient not measured"]},{"year":2005,"claim":"Mapped organ-specific RALDH2 functions across pharyngeal, pancreatic, ocular, limb, and neural development, establishing it as a master source of patterning RA.","evidence":"Raldh2 knockout/conditional-rescue mice with RA reporters and maternal RA rescue across multiple organ systems","pmids":["12702665","16026781","15366004","15069081","15652703"],"confidence":"High","gaps":["Downstream transcriptional targets of RA differ per organ and remain partial","Timing thresholds not fully defined"]},{"year":2005,"claim":"Linked ALDH1A2 enzymatic activity to tumor-suppressive function, showing the RA-synthesizing activity is required for growth suppression.","evidence":"Wild-type vs. catalytic mutant re-expression in DU145 prostate cancer cells, colony assay","pmids":["16166285"],"confidence":"Medium","gaps":["Catalytic mutant only minimally characterized","Single cell line, mechanism downstream of RA not defined"]},{"year":2011,"claim":"Revealed context-dependent pro-tumor effects of ALDH1A2 overexpression and clarified Aldefluor/DEAB assay specificity across ALDH isoforms.","evidence":"Lentiviral overexpression, Aldefluor flow cytometry, DEAB inhibition in K562/H1299 cells","pmids":["22079344"],"confidence":"Medium","gaps":["Opposite to tumor-suppressive role elsewhere; context determinants unknown","Single lab, drug-resistance mechanism not defined"]},{"year":2011,"claim":"Identified WT1 as a direct transcriptional activator linking epicardial cell identity to RALDH2-driven RA synthesis and PDGFRα expression.","evidence":"Wt1-null epicardial cells, RA reporter, transcriptional target analysis, rescue","pmids":["21343363"],"confidence":"Medium","gaps":["Direct promoter binding inferred rather than fully mapped","Single lab"]},{"year":2018,"claim":"Resolved the structural basis of catalysis and inhibition, showing WIN18,446 covalently modifies Cys320 and distorts NAD into a catalytically incompetent conformation.","evidence":"X-ray crystallography of human ALDH1A2 with multiple inhibitor chemotypes","pmids":["29240402"],"confidence":"High","gaps":["Apo and fully catalytic states resolved only later","Substrate-bound Michaelis complex not captured"]},{"year":2021,"claim":"Established direct human disease causation: biallelic hypomorphic variants reducing RA production cause a lethal multiple congenital anomaly syndrome.","evidence":"Exome sequencing in two families, in vitro RA synthesis assays, in silico modeling","pmids":["33565183"],"confidence":"Medium","gaps":["Structural impact partly computational","Genotype-phenotype range not fully defined"]},{"year":2021,"claim":"Defined an upstream transcriptional cascade in which Tbx5 maintains aldh1a2 via a conserved intronic enhancer to coordinate cardiopulmonary development.","evidence":"Xenopus and mouse enhancer reporters, genetic epistasis, in situ hybridization","pmids":["34643182"],"confidence":"High","gaps":["Other enhancer inputs in non-cardiac tissues not characterized"]},{"year":2018,"claim":"Dissected the dendritic-cell transcriptional control of RALDH2, identifying cooperative Sp1/RAR-RXR, RBPJ-Notch, and PU.1/IRF4 inputs plus PPARγ-directed pathway assembly governing tolerogenic RA production.","evidence":"ChIP, EMSA, reporter assays, siRNA, DC-specific knockouts, pathway reconstitution in DC subsets","pmids":["24788806","28779023","30413670","23833249"],"confidence":"High","gaps":["Combinatorial integration of these inputs not fully reconstituted","Mostly mouse DC systems"]},{"year":2015,"claim":"Mapped repressive and restrictive transcriptional regulators (Foxc1a, HOXA13, Wnt/β-catenin) that spatially bound and tune aldh1a2 expression in developing tissues.","evidence":"ChIP, genetic nulls/epistasis, luciferase reporters in zebrafish, mouse, and kidney cells","pmids":["25724646","23553814","32258025"],"confidence":"High","gaps":["Cross-talk among activators and repressors at the locus not integrated"]},{"year":2022,"claim":"Demonstrated cell-type-specific adult requirement: Sertoli-cell RALDH2-derived RA drives the initial round of spermatogonial differentiation, non-redundant with ALDH1A3.","evidence":"Global and cell-specific Cre-loxP knockout mice, histology","pmids":["35574006"],"confidence":"High","gaps":["RA target genes in germ cells not fully defined"]},{"year":2022,"claim":"Established a cartilage-protective role through PPARγ-dependent suppression of mechanoflammation, linking reduced ALDH1A2/RA to osteoarthritis.","evidence":"RNA-seq of genotype-stratified human OA cartilage, talarozole treatment in vitro and in mouse joint-injury models, RNAi in chondrocytes","pmids":["36542696","29732726"],"confidence":"High","gaps":["Direct enzyme-PPARγ mechanistic coupling not fully resolved","Therapeutic translation unproven"]},{"year":2020,"claim":"Expanded the regulatory and physiological repertoire to post-transcriptional control (TTP), a ROBO2 binding partner in ureter development, regeneration, ocular growth, milky-spot stroma, and paracrine immune circuits.","evidence":"Zfp36 knockout, Co-IP with ROBO2 and RA rescue, zebrafish regeneration, chick choroid RA quantification, cell ablation, DC pathway dissection","pmids":["32467605","32562756","19801676","22323456","36880532","32209473"],"confidence":"Medium","gaps":["ROBO2-RALDH2 interaction is single Co-IP without reciprocal validation","Several roles are single-lab functional associations"]},{"year":2026,"claim":"Defined an autocrine RA brake on DC maturation and a cardioprotective RA→RAR→Bmp7 axis, and developed selective inhibitors enabling therapeutic targeting.","evidence":"Aldh1a2 DC and cardiomyocyte conditional knockouts/overexpression, small-molecule inhibitors, DC vaccine and I/R injury assays","pmids":["41491403","41689430"],"confidence":"High","gaps":["Inhibitor selectivity over ALDH1A1/ALDH2 in vivo not fully resolved","Bmp7 regulation mechanism partial"]},{"year":2025,"claim":"Extended structural and mechanistic understanding with the apo structure and direct mass-spectrometric confirmation of the Cys319 covalent adduct underlying irreversible inhibition.","evidence":"Apo X-ray structure, LC-MS/MS adduct identification in human liver","pmids":["40829477","42124481"],"confidence":"High","gaps":["No functional mutagenesis of apo structure reported","Isoform-selective targeting still limited by shared catalytic cysteine"]},{"year":null,"claim":"How the diverse activating and repressing transcription factors are combinatorially integrated at the ALDH1A2 locus to produce spatially precise RA gradients, and how RALDH2 inhibition can be made isoform-selective given the shared active-site cysteine, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of cis-regulatory integration","No isoform-selective covalent inhibitor mechanism established","RA receptor effector logic differs across tissues"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[1,2,13,33]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,4,5,6,7,8,9,19]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,2]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[15,16,17,28,38]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,9,35]}],"complexes":[],"partners":["ROBO2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O94788","full_name":"Retinal dehydrogenase 2","aliases":["Aldehyde dehydrogenase family 1 member A2","ALDH1A2","Retinaldehyde-specific dehydrogenase type 2","RALDH(II)"],"length_aa":518,"mass_kda":56.7,"function":"Catalyzes the NAD-dependent oxidation of aldehyde substrates, such as all-trans-retinal and all-trans-13,14-dihydroretinal, to their corresponding carboxylic acids, all-trans-retinoate and all-trans-13,14-dihydroretinoate, respectively (PubMed:29240402, PubMed:33565183). Retinoate signaling is critical for the transcriptional control of many genes, for instance it is crucial for initiation of meiosis in both male and female (Probable) (PubMed:33565183). Recognizes retinal as substrate, both in its free form and when bound to cellular retinol-binding protein (By similarity). Can metabolize octanal and decanal, but has only very low activity with benzaldehyde, acetaldehyde and propanal (By similarity). Displays complete lack of activity with citral (By similarity)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O94788/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ALDH1A2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ALDH1A2","total_profiled":1310},"omim":[{"mim_id":"620025","title":"DIAPHRAGMATIC HERNIA 4, WITH CARDIOVASCULAR DEFECTS; DIH4","url":"https://www.omim.org/entry/620025"},{"mim_id":"610507","title":"LEO1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT; LEO1","url":"https://www.omim.org/entry/610507"},{"mim_id":"606264","title":"C-TYPE LECTIN DOMAIN FAMILY 7, MEMBER A; CLEC7A","url":"https://www.omim.org/entry/606264"},{"mim_id":"603687","title":"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A2; ALDH1A2","url":"https://www.omim.org/entry/603687"},{"mim_id":"603028","title":"TOLL-LIKE RECEPTOR 2; TLR2","url":"https://www.omim.org/entry/603028"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"endometrium 1","ntpm":76.9},{"tissue":"fallopian tube","ntpm":70.1}],"url":"https://www.proteinatlas.org/search/ALDH1A2"},"hgnc":{"alias_symbol":["RALDH2"],"prev_symbol":[]},"alphafold":{"accession":"O94788","domains":[{"cath_id":"3.40.605.10","chopping":"41-288_493-506","consensus_level":"high","plddt":98.6835,"start":41,"end":506},{"cath_id":"3.40.309.10","chopping":"293-479","consensus_level":"high","plddt":98.3082,"start":293,"end":479}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94788","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94788-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94788-F1-predicted_aligned_error_v6.png","plddt_mean":95.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ALDH1A2","jax_strain_url":"https://www.jax.org/strain/search?query=ALDH1A2"},"sequence":{"accession":"O94788","fasta_url":"https://rest.uniprot.org/uniprotkb/O94788.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94788/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94788"}},"corpus_meta":[{"pmid":"9106168","id":"PMC_9106168","title":"Restricted expression and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse development.","date":"1997","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9106168","citation_count":414,"is_preprint":false},{"pmid":"11688558","id":"PMC_11688558","title":"The zebrafish neckless mutation reveals a requirement for raldh2 in mesodermal signals that pattern the hindbrain.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11688558","citation_count":314,"is_preprint":false},{"pmid":"11959834","id":"PMC_11959834","title":"Novel retinoic acid generating activities in the neural tube and heart identified by conditional rescue of Raldh2 null mutant mice.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11959834","citation_count":214,"is_preprint":false},{"pmid":"16026781","id":"PMC_16026781","title":"Dorsal pancreas agenesis in retinoic acid-deficient Raldh2 mutant mice.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16026781","citation_count":195,"is_preprint":false},{"pmid":"12086469","id":"PMC_12086469","title":"Experimental studies on the spatiotemporal expression of WT1 and RALDH2 in the embryonic avian heart: a model for the regulation of myocardial and valvuloseptal development by epicardially derived cells (EPDCs).","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12086469","citation_count":190,"is_preprint":false},{"pmid":"12702665","id":"PMC_12702665","title":"The regional pattern of retinoic acid synthesis by RALDH2 is essential for the development of posterior pharyngeal arches and the enteric nervous system.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12702665","citation_count":177,"is_preprint":false},{"pmid":"22079344","id":"PMC_22079344","title":"The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.","date":"2011","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/22079344","citation_count":164,"is_preprint":false},{"pmid":"15739227","id":"PMC_15739227","title":"Retinoic acid generated by Raldh2 in mesoderm is required for mouse dorsal endodermal pancreas development.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15739227","citation_count":163,"is_preprint":false},{"pmid":"13129847","id":"PMC_13129847","title":"A caudorostral wave of RALDH2 conveys anteroposterior information to the cardiac field.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/13129847","citation_count":150,"is_preprint":false},{"pmid":"10357892","id":"PMC_10357892","title":"Differential distribution of retinoic acid synthesis in the chicken embryo as determined by immunolocalization of the retinoic acid synthetic enzyme, RALDH-2.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10357892","citation_count":147,"is_preprint":false},{"pmid":"16166285","id":"PMC_16166285","title":"The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16166285","citation_count":127,"is_preprint":false},{"pmid":"10570467","id":"PMC_10570467","title":"Distinct functions for Aldh1 and Raldh2 in the control of ligand production for embryonic retinoid signaling pathways.","date":"1999","source":"Developmental genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10570467","citation_count":125,"is_preprint":false},{"pmid":"24728293","id":"PMC_24728293","title":"Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24728293","citation_count":118,"is_preprint":false},{"pmid":"21343363","id":"PMC_21343363","title":"Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21343363","citation_count":111,"is_preprint":false},{"pmid":"16368932","id":"PMC_16368932","title":"Retinaldehyde dehydrogenase 2 (RALDH2)-mediated retinoic acid synthesis regulates early mouse embryonic forebrain development by controlling FGF and sonic hedgehog signaling.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16368932","citation_count":104,"is_preprint":false},{"pmid":"12454286","id":"PMC_12454286","title":"Retinaldehyde dehydrogenase 2 (RALDH2)- independent patterns of retinoic acid synthesis in the mouse embryo.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12454286","citation_count":98,"is_preprint":false},{"pmid":"15652703","id":"PMC_15652703","title":"Requirement of mesodermal retinoic acid generated by Raldh2 for posterior neural transformation.","date":"2005","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/15652703","citation_count":83,"is_preprint":false},{"pmid":"15366004","id":"PMC_15366004","title":"Raldh2 expression in optic vesicle generates a retinoic acid signal needed for invagination of retina during optic cup formation.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15366004","citation_count":77,"is_preprint":false},{"pmid":"15069081","id":"PMC_15069081","title":"Retinoic acid synthesis controlled by Raldh2 is required early for limb bud initiation and then later as a proximodistal signal during apical ectodermal ridge formation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15069081","citation_count":77,"is_preprint":false},{"pmid":"25976364","id":"PMC_25976364","title":"Retinoic acid homeostasis through aldh1a2 and cyp26a1 mediates meiotic entry in Nile tilapia (Oreochromis niloticus).","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25976364","citation_count":76,"is_preprint":false},{"pmid":"19801676","id":"PMC_19801676","title":"Comparative expression profiling reveals an essential role for raldh2 in epimorphic regeneration.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19801676","citation_count":66,"is_preprint":false},{"pmid":"29240402","id":"PMC_29240402","title":"Structural Basis of ALDH1A2 Inhibition by Irreversible and Reversible Small Molecule Inhibitors.","date":"2018","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/29240402","citation_count":60,"is_preprint":false},{"pmid":"12799071","id":"PMC_12799071","title":"Expression of Raldh2, Cyp26 and Hox-1 in normal and retinoic acid-treated Ciona intestinalis embryos.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12799071","citation_count":56,"is_preprint":false},{"pmid":"26972771","id":"PMC_26972771","title":"Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-10 and TGF-β.","date":"2016","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26972771","citation_count":51,"is_preprint":false},{"pmid":"23960232","id":"PMC_23960232","title":"IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23960232","citation_count":50,"is_preprint":false},{"pmid":"15343149","id":"PMC_15343149","title":"Early transcriptional changes of retinal and choroidal TGFbeta-2, RALDH-2, and ZENK following imposed positive and negative defocus in chickens.","date":"2004","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15343149","citation_count":50,"is_preprint":false},{"pmid":"11983430","id":"PMC_11983430","title":"Kinetic analysis of mouse retinal dehydrogenase type-2 (RALDH2) for retinal substrates.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11983430","citation_count":49,"is_preprint":false},{"pmid":"16237707","id":"PMC_16237707","title":"Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2.","date":"2005","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/16237707","citation_count":46,"is_preprint":false},{"pmid":"11751205","id":"PMC_11751205","title":"Alveolar proliferation, retinoid synthesizing enzymes, and endogenous retinoids in the postnatal mouse lung. Different roles for Aldh-1 and Raldh-2.","date":"2002","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11751205","citation_count":43,"is_preprint":false},{"pmid":"29732726","id":"PMC_29732726","title":"Functional Characterization of the Osteoarthritis Genetic Risk Residing at ALDH1A2 Identifies rs12915901 as a Key Target Variant.","date":"2018","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/29732726","citation_count":41,"is_preprint":false},{"pmid":"19886994","id":"PMC_19886994","title":"ALDH1A2 (RALDH2) genetic variation in human congenital heart disease.","date":"2009","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19886994","citation_count":40,"is_preprint":false},{"pmid":"36542696","id":"PMC_36542696","title":"Variants in ALDH1A2 reveal an anti-inflammatory role for retinoic acid and a new class of disease-modifying drugs in osteoarthritis.","date":"2022","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36542696","citation_count":38,"is_preprint":false},{"pmid":"20375987","id":"PMC_20375987","title":"A human ALDH1A2 gene variant is associated with increased newborn kidney size and serum retinoic acid.","date":"2010","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/20375987","citation_count":38,"is_preprint":false},{"pmid":"17180597","id":"PMC_17180597","title":"Expression of retinaldehyde dehydrogenase (RALDH)2 and RALDH3 but not RALDH1 in the developing anterior pituitary glands of rats.","date":"2006","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/17180597","citation_count":36,"is_preprint":false},{"pmid":"19549509","id":"PMC_19549509","title":"Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.","date":"2009","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19549509","citation_count":34,"is_preprint":false},{"pmid":"22733143","id":"PMC_22733143","title":"RALDH2, the enzyme for retinoic acid synthesis, mediates meiosis initiation in germ cells of the female embryonic chickens.","date":"2012","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/22733143","citation_count":33,"is_preprint":false},{"pmid":"31615043","id":"PMC_31615043","title":"ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31615043","citation_count":30,"is_preprint":false},{"pmid":"22323456","id":"PMC_22323456","title":"Identification of RALDH2 as a visually regulated retinoic acid synthesizing enzyme in the chick choroid.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22323456","citation_count":30,"is_preprint":false},{"pmid":"20011517","id":"PMC_20011517","title":"Maternal and zygotic aldh1a2 activity is required for pancreas development in zebrafish.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20011517","citation_count":27,"is_preprint":false},{"pmid":"15245423","id":"PMC_15245423","title":"Hair cycle-specific immunolocalization of retinoic acid synthesizing enzymes Aldh1a2 and Aldh1a3 indicate complex regulation.","date":"2004","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15245423","citation_count":27,"is_preprint":false},{"pmid":"24788806","id":"PMC_24788806","title":"Retinoic acid and GM-CSF coordinately induce retinal dehydrogenase 2 (RALDH2) expression through cooperation between the RAR/RXR complex and Sp1 in dendritic cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24788806","citation_count":26,"is_preprint":false},{"pmid":"18478160","id":"PMC_18478160","title":"Expression of the retinoic acid-metabolizing enzymes RALDH2 and CYP26b1 during mouse postnatal testis development.","date":"2008","source":"Asian journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/18478160","citation_count":25,"is_preprint":false},{"pmid":"34643182","id":"PMC_34643182","title":"Tbx5 drives Aldh1a2 expression to regulate a RA-Hedgehog-Wnt gene regulatory network coordinating cardiopulmonary development.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34643182","citation_count":24,"is_preprint":false},{"pmid":"23833249","id":"PMC_23833249","title":"RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells.","date":"2013","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/23833249","citation_count":24,"is_preprint":false},{"pmid":"25724646","id":"PMC_25724646","title":"Zebrafish foxc1a plays a crucial role in early somitogenesis by restricting the expression of aldh1a2 directly.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25724646","citation_count":24,"is_preprint":false},{"pmid":"29430185","id":"PMC_29430185","title":"ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3.","date":"2018","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29430185","citation_count":23,"is_preprint":false},{"pmid":"19703508","id":"PMC_19703508","title":"Positive association between ALDH1A2 and schizophrenia in the Chinese population.","date":"2009","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19703508","citation_count":23,"is_preprint":false},{"pmid":"10858567","id":"PMC_10858567","title":"Mouse type-2 retinaldehyde dehydrogenase (RALDH2): genomic organization, tissue-dependent expression, chromosome assignment and comparison to other types.","date":"2000","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10858567","citation_count":23,"is_preprint":false},{"pmid":"24377748","id":"PMC_24377748","title":"Duplication of the ALDH1A2 gene in association with pentalogy of Cantrell: a case report.","date":"2013","source":"Journal of medical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/24377748","citation_count":23,"is_preprint":false},{"pmid":"20081195","id":"PMC_20081195","title":"Insights into the organization of dorsal spinal cord pathways from an evolutionarily conserved raldh2 intronic enhancer.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20081195","citation_count":23,"is_preprint":false},{"pmid":"11507765","id":"PMC_11507765","title":"Expression and regulation of the retinoic acid synthetic enzyme RALDH-2 in the embryonic chicken wing.","date":"2001","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/11507765","citation_count":23,"is_preprint":false},{"pmid":"11472854","id":"PMC_11472854","title":"Specific expression of the retinoic acid-synthesizing enzyme RALDH2 during mouse inner ear development.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11472854","citation_count":22,"is_preprint":false},{"pmid":"33378690","id":"PMC_33378690","title":"Peanut protein acts as a TH2 adjuvant by inducing RALDH2 in human antigen-presenting cells.","date":"2020","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33378690","citation_count":22,"is_preprint":false},{"pmid":"30381402","id":"PMC_30381402","title":"CD16+ monocytes give rise to CD103+RALDH2+TCF4+ dendritic cells with unique transcriptional and immunological features.","date":"2018","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/30381402","citation_count":21,"is_preprint":false},{"pmid":"33565183","id":"PMC_33565183","title":"Biallelic hypomorphic variants in ALDH1A2 cause a novel lethal human multiple congenital anomaly syndrome encompassing diaphragmatic, pulmonary, and cardiovascular defects.","date":"2021","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/33565183","citation_count":19,"is_preprint":false},{"pmid":"36880532","id":"PMC_36880532","title":"Aldh1a2 + fibroblastic reticular cells regulate lymphocyte recruitment in omental milky spots.","date":"2023","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36880532","citation_count":18,"is_preprint":false},{"pmid":"27569851","id":"PMC_27569851","title":"Expression of retinoic acid-metabolizing enzymes, ALDH1A1, ALDH1A2, ALDH1A3, CYP26A1, CYP26B1 and CYP26C1 in canine testis during post-natal development.","date":"2016","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/27569851","citation_count":18,"is_preprint":false},{"pmid":"14623241","id":"PMC_14623241","title":"Patterning of forelimb bud myogenic precursor cells requires retinoic acid signaling initiated by Raldh2.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14623241","citation_count":18,"is_preprint":false},{"pmid":"28089900","id":"PMC_28089900","title":"The rs4238326 polymorphism in ALDH1A2 gene potentially associated with non-post traumatic knee osteoarthritis susceptibility: a two-stage population-based study.","date":"2017","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/28089900","citation_count":18,"is_preprint":false},{"pmid":"35574006","id":"PMC_35574006","title":"Global Deletion of ALDH1A1 and ALDH1A2 Genes Does Not Affect Viability but Blocks Spermatogenesis.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35574006","citation_count":17,"is_preprint":false},{"pmid":"24056063","id":"PMC_24056063","title":"Retinoic acid homeostasis regulates meiotic entry in developing anuran gonads and in Bidder's organ through Raldh2 and Cyp26b1 proteins.","date":"2013","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/24056063","citation_count":17,"is_preprint":false},{"pmid":"28779023","id":"PMC_28779023","title":"Notch Balances Th17 and Induced Regulatory T Cell Functions in Dendritic Cells by Regulating Aldh1a2 Expression.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28779023","citation_count":16,"is_preprint":false},{"pmid":"22592974","id":"PMC_22592974","title":"New sources of retinoic acid synthesis revealed by live imaging of an Aldh1a2-GFP reporter fusion protein throughout zebrafish development.","date":"2012","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/22592974","citation_count":16,"is_preprint":false},{"pmid":"30413670","id":"PMC_30413670","title":"The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30413670","citation_count":15,"is_preprint":false},{"pmid":"34572134","id":"PMC_34572134","title":"The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34572134","citation_count":13,"is_preprint":false},{"pmid":"23553814","id":"PMC_23553814","title":"HOXA13 regulates Aldh1a2 expression in the autopod to facilitate interdigital programmed cell death.","date":"2013","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/23553814","citation_count":13,"is_preprint":false},{"pmid":"32209473","id":"PMC_32209473","title":"CD137 Signaling Regulates Acute Colitis via RALDH2-Expressing CD11b-CD103+ DCs.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32209473","citation_count":13,"is_preprint":false},{"pmid":"36263470","id":"PMC_36263470","title":"ALDH1A2-related disorder: A new genetic syndrome due to alteration of the retinoic acid pathway.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/36263470","citation_count":13,"is_preprint":false},{"pmid":"16496350","id":"PMC_16496350","title":"Conditional (loxP-flanked) allele for the gene encoding the retinoic acid-synthesizing enzyme retinaldehyde dehydrogenase 2 (RALDH2).","date":"2006","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/16496350","citation_count":12,"is_preprint":false},{"pmid":"24236815","id":"PMC_24236815","title":"Methylation of a CpG site near the ALDH1A2 gene is associated with loss of control over drinking and related phenotypes.","date":"2013","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/24236815","citation_count":11,"is_preprint":false},{"pmid":"27897208","id":"PMC_27897208","title":"Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27897208","citation_count":11,"is_preprint":false},{"pmid":"32849526","id":"PMC_32849526","title":"Age-Dependent Decrease in the Induction of Regulatory T Cells Is Associated With Decreased Expression of RALDH2 in Mesenteric Lymph Node Dendritic Cells.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32849526","citation_count":11,"is_preprint":false},{"pmid":"39521994","id":"PMC_39521994","title":"The therapeutic potential of Apigenin in amyotrophic lateral sclerosis through ALDH1A2/Nrf2/ARE signaling.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/39521994","citation_count":10,"is_preprint":false},{"pmid":"20423710","id":"PMC_20423710","title":"prep1.2 and aldh1a2 participate to a positive loop required for branchial arches development in zebrafish.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20423710","citation_count":9,"is_preprint":false},{"pmid":"29967615","id":"PMC_29967615","title":"The Microenvironment in Barrett's Esophagus Tissue Is Characterized by High FOXP3 and RALDH2 Levels.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29967615","citation_count":8,"is_preprint":false},{"pmid":"17177861","id":"PMC_17177861","title":"Rescue of morphogenetic defects and of retinoic acid signaling in retinaldehyde dehydrogenase 2 (Raldh2) mouse mutants by chimerism with wild-type cells.","date":"2006","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/17177861","citation_count":8,"is_preprint":false},{"pmid":"32258025","id":"PMC_32258025","title":"Inhibition of GSK3 Represses the Expression of Retinoic Acid Synthetic Enzyme ALDH1A2 via Wnt/β-Catenin Signaling in WiT49 Cells.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32258025","citation_count":7,"is_preprint":false},{"pmid":"30651234","id":"PMC_30651234","title":"Cux2 refines the forelimb field by controlling expression of Raldh2 and Hox genes.","date":"2019","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/30651234","citation_count":7,"is_preprint":false},{"pmid":"39060515","id":"PMC_39060515","title":"Non-canonical NF-κB signaling limits the tolerogenic β-catenin-Raldh2 axis in gut dendritic cells to exacerbate intestinal pathologies.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/39060515","citation_count":6,"is_preprint":false},{"pmid":"37146794","id":"PMC_37146794","title":"Dysregulation of Aldh1a2 underlies motor neuron degeneration in spinal muscular atrophy.","date":"2023","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/37146794","citation_count":5,"is_preprint":false},{"pmid":"35388759","id":"PMC_35388759","title":"Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).","date":"2022","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/35388759","citation_count":5,"is_preprint":false},{"pmid":"32467605","id":"PMC_32467605","title":"The RNA-binding protein tristetraprolin regulates RALDH2 expression by intestinal dendritic cells and controls local Treg homeostasis.","date":"2020","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32467605","citation_count":5,"is_preprint":false},{"pmid":"41491403","id":"PMC_41491403","title":"Targeting autocrine retinoic acid signaling by ALDH1A2 inhibition enhances antitumor dendritic cell vaccine efficacy.","date":"2026","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41491403","citation_count":4,"is_preprint":false},{"pmid":"38441233","id":"PMC_38441233","title":"A functional variant of ALDH1A2 is associated with hand osteoarthritis in the Chinese population.","date":"2024","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/38441233","citation_count":3,"is_preprint":false},{"pmid":"20483243","id":"PMC_20483243","title":"Molecular cloning and expression of retinoic-acid synthesizing enzyme raldh2 from Takifugu rubripes.","date":"2005","source":"Comparative biochemistry and physiology. Part D, Genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/20483243","citation_count":3,"is_preprint":false},{"pmid":"19455414","id":"PMC_19455414","title":"Opossum aldehyde dehydrogenases: evidence for four ALDH1A1-like genes on chromosome 6 and ALDH1A2 and ALDH1A3 genes on chromosome 1.","date":"2009","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19455414","citation_count":3,"is_preprint":false},{"pmid":"35059888","id":"PMC_35059888","title":"An eQTL variant of ALDH1A2 is associated with Kashin-Beck disease in Chinese population.","date":"2022","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35059888","citation_count":2,"is_preprint":false},{"pmid":"32562756","id":"PMC_32562756","title":"ROBO2-mediated RALDH2 signaling is required for common nephric duct fusion with primitive bladder.","date":"2020","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32562756","citation_count":2,"is_preprint":false},{"pmid":"39360029","id":"PMC_39360029","title":"Single-cell RNA sequencing data locate ALDH1A2-mediated retinoic acid synthetic pathway to glomerular parietal epithelial cells.","date":"2024","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/39360029","citation_count":1,"is_preprint":false},{"pmid":"20450613","id":"PMC_20450613","title":"[Effects of 5-Aza-2'-deoxycitydine and trichostatin A on expression and apoptosis of ALDH1a2 gene in human bladder cancer cell lines].","date":"2010","source":"Zhonghua wai ke za zhi [Chinese journal of surgery]","url":"https://pubmed.ncbi.nlm.nih.gov/20450613","citation_count":1,"is_preprint":false},{"pmid":"41558294","id":"PMC_41558294","title":"PTPN2 alleviates Silicotic pulmonary fibrosis by inhibiting senescence of type II alveolar epithelial cells via retinol metabolism regulated by ALDH1A2.","date":"2026","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41558294","citation_count":1,"is_preprint":false},{"pmid":"41382115","id":"PMC_41382115","title":"Intratracheal administration of mesenchymal stem cells ameliorates hyperoxia-induced bronchopulmonary dysplasia by inhibiting NLRP3 inflammasome activation: the critical role of Aldh1a2.","date":"2025","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/41382115","citation_count":1,"is_preprint":false},{"pmid":"41689430","id":"PMC_41689430","title":"Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury.","date":"2026","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/41689430","citation_count":0,"is_preprint":false},{"pmid":"39781359","id":"PMC_39781359","title":"Uncovering the Role of ALDH1A2 in Prostate Cancer: Insights from Genetic and Expression Analyses.","date":"2025","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39781359","citation_count":0,"is_preprint":false},{"pmid":"40829477","id":"PMC_40829477","title":"Exploiting ALDH1A2 and ALDH1A3 isoform variability for crystallisation screening.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40829477","citation_count":0,"is_preprint":false},{"pmid":"40543226","id":"PMC_40543226","title":"ZBTB12 promotes breast cancer progression through transcriptional activation of the DNMT3B/ALDH1A2 axis.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40543226","citation_count":0,"is_preprint":false},{"pmid":"42124481","id":"PMC_42124481","title":"Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry.","date":"2026","source":"Drug metabolism reviews","url":"https://pubmed.ncbi.nlm.nih.gov/42124481","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.16.628661","title":"Modelling co-development between the somites and neural tube in human Trunk-like Structures (hTLS)","date":"2024-12-17","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.16.628661","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.06.657928","title":"WNT signaling in human pluripotent stem cells promotes HDAC2-dependent epigenetic programs and development of retinoic acid-responsive mesoderm","date":"2025-06-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.06.657928","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.11.642712","title":"Harnessing ALDH1A2 vulnerability in T-cell acute lymphoblastic leukemia","date":"2025-03-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.11.642712","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53345,"output_tokens":9778,"usd":0.153353,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20330,"output_tokens":5396,"usd":0.118275,"stage2_stop_reason":"end_turn"},"total_usd":0.271628,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"RALDH2 (ALDH1A2) was identified as a major retinoic acid (RA)-generating enzyme in the early mouse embryo; its expression in mesoderm marks sites of endogenous RA synthesis, and exogenous RA administration downregulates RALDH2 transcript levels, suggesting a negative feedback mechanism on RA synthesis.\",\n      \"method\": \"In situ hybridization, RA administration experiments in mouse embryos\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated across multiple labs with orthogonal methods; foundational study establishing enzymatic identity and negative feedback\",\n      \"pmids\": [\"9106168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Kinetic analysis of purified recombinant mouse RALDH2 demonstrated that it catalyzes oxidation of retinal to retinoic acid with a pH optimum of 9.0, with highest catalytic efficiency for all-trans retinal (Km ~0.66 µM) compared to 9-cis retinal (Km ~2.25 µM); the enzyme is inhibited by citral and p-HMB, and activated by MgCl2.\",\n      \"method\": \"In vitro enzyme kinetics using purified recombinant RALDH2\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro enzymatic characterization with purified recombinant protein and multiple substrate/inhibitor conditions\",\n      \"pmids\": [\"11983430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Injection of mouse Raldh2 mRNA into Xenopus embryos stimulates RA synthesis at high levels in vivo, whereas ALDH3 mRNA injection produces no detectable RA synthesis, establishing Raldh2 as a genuine RA-synthesizing enzyme in vivo. Immunohistochemistry showed RALDH2 protein is localized primarily in trunk tissues (paraxial mesoderm, somites, pericardium, midgut, mesonephros) at E7.5–E10.5.\",\n      \"method\": \"Xenopus mRNA injection with RA activity assay; whole-mount immunohistochemistry in mouse embryos\",\n      \"journal\": \"Developmental genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vivo functional assay combined with immunolocalization, replicated concept across labs\",\n      \"pmids\": [\"10570467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Targeted disruption of Raldh2 in mice arrests development at midgestation and eliminates nearly all RA synthesis in the embryo (except RALDH3-dependent activity in the surface ectoderm of the eye field), demonstrating that RALDH2 is responsible for most embryonic RA synthesis. Conditional rescue by limited maternal RA revealed additional RA-generating activities in the neural tube and heart not corresponding to Raldh1–3.\",\n      \"method\": \"Raldh2 knockout mice, RA-responsive transgene reporter, maternal RA rescue\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic null with RA reporter and rescue experiment; replicated finding across multiple papers\",\n      \"pmids\": [\"11959834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The zebrafish neckless mutation inactivates Raldh2, causing truncation of the anteroposterior axis, midline mesendodermal defects, and absence of pectoral fins. Mosaic analysis showed that reduced hoxb4 expression in the nervous system is non-cell-autonomous, reflecting a requirement for RA signaling from adjacent paraxial mesoderm.\",\n      \"method\": \"Zebrafish forward genetics, mosaic analysis, RA rescue experiment\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with mosaic analysis and RA rescue; establishes non-cell-autonomous mesoderm-to-neural signaling role\",\n      \"pmids\": [\"11688558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Raldh2 is the enzyme responsible for RA synthesis in the posterior pharyngeal mesoderm; its inactivation (with early rescue) causes failure of posterior pharyngeal pouch formation, impaired neural crest migration, and agenesis of enteric ganglia resembling Hirschsprung's disease, establishing RALDH2-generated RA as a mesodermal signal patterning pharyngeal endoderm.\",\n      \"method\": \"Raldh2 conditional knockout mice (RA-rescued), in situ hybridization, in vivo phenotype analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic null with conditional rescue and mechanistic pathway placement\",\n      \"pmids\": [\"12702665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Raldh2 expressed in dorsal pancreatic mesenchyme provides RA signal to dorsal endoderm required for Pdx1 and Isl1 expression and dorsal pancreatic bud formation; Raldh2−/− embryos specifically lack dorsal but not ventral pancreatic development, and maternal RA supplementation rescues these defects.\",\n      \"method\": \"Raldh2 knockout mice, in situ hybridization, RA reporter transgene, maternal RA rescue\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods in knockout with rescue, replicated across two independent studies (PMIDs 16026781 and 15739227)\",\n      \"pmids\": [\"16026781\", \"15739227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Raldh2 in the optic vesicle generates a RA signal required for retina invagination and optic cup formation; Raldh2−/− embryos fail to develop an optic cup, and maternal RA administration rescues this defect. RALDH3 activity in the lens placode is insufficient to substitute.\",\n      \"method\": \"Raldh2 knockout and Raldh1/Raldh2 double-knockout mice, RA reporter, maternal RA rescue\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic nulls with rescue and epistatic comparison of multiple Raldh family members\",\n      \"pmids\": [\"15366004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Raldh2 in lateral plate mesoderm controls two phases of RA signaling for limb development: an early phase (E8) upstream of Tbx5, Meis2, and dHand for forelimb bud initiation, and a late phase providing a proximodistal RA gradient for AER expansion. Raldh2−/− embryos fail to initiate forelimbs; selective RA rescue at E8 restores initiation but not full AER formation.\",\n      \"method\": \"Raldh2 knockout mice, RA reporter transgene, timed maternal RA administration, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic null with temporally controlled rescue establishing two distinct signaling phases\",\n      \"pmids\": [\"15069081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Raldh2 in somitic mesoderm is required for posterior neural transformation (spinal cord fate specification); Raldh2−/− embryos show loss of Pax6 and Olig2 in posterior neural plate, and RA generated by Raldh2 acts directly in neuroectoderm (not somitic mesoderm) to promote spinal cord differentiation while also suppressing Fgf8 in the tailbud.\",\n      \"method\": \"Raldh2 knockout mice, in situ hybridization, RA reporter transgene, maternal RA rescue\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic null with RA reporter distinguishing cell-autonomous vs. non-cell-autonomous action\",\n      \"pmids\": [\"15652703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Transfection-mediated re-expression of wild-type ALDH1A2 (but not a presumptive catalytically dead mutant) in the prostate cancer cell line DU145 decreased colony growth, demonstrating that ALDH1A2 tumor-suppressive activity depends on its enzymatic (RA-synthesizing) function.\",\n      \"method\": \"Transfection of wild-type vs. catalytic mutant ALDH1A2 in DU145 cells, colony formation assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, catalytic mutant experiment establishing enzymatic requirement, but limited characterization of mutant\",\n      \"pmids\": [\"16166285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ALDH1A2 and ALDH2 enzymatic activity is detected by the Aldefluor assay; DEAB inhibits both isoenzymes (65–90% reduction), demonstrating that DEAB is not specific for ALDH1A1. Overexpression of ALDH1A2 in K562 and H1299 cells increased cell proliferation, clonal efficiency, and resistance to 4-hydroperoxycyclophosphamide and doxorubicin.\",\n      \"method\": \"Lentiviral overexpression, activity assay, Aldefluor flow cytometry, DEAB inhibition, Western blot\",\n      \"journal\": \"Chemico-biological interactions\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional overexpression with enzymatic activity measurements and pharmacological inhibition, single lab\",\n      \"pmids\": [\"22079344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"WT1 (Wilms Tumor 1) transcription factor directly activates Raldh2 transcription in epicardial cells; Wt1-null epicardial cells display decreased Raldh2 expression and reduced RA synthesis. WT1 was shown to be a direct transcriptional activator of Raldh2, and PDGFRα expression (but not RXRα) is rescued by RA addition to Wt1-null cells.\",\n      \"method\": \"In vivo and in vitro Wt1 knockout epicardial cells, RA-responsive reporter, ChIP (implied by 'direct transcriptional target' statement), rescue experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with functional RA reporter and direct transcriptional target demonstration, single lab\",\n      \"pmids\": [\"21343363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"X-ray crystal structures of human ALDH1A2 in complex with irreversible inhibitor WIN18,446 revealed that WIN18,446 covalently modifies the catalytic residue Cys320, forming a chiral adduct in (R) configuration that distorts the neighboring NAD cofactor into a contracted conformation suboptimal for the dehydrogenase reaction. Reversible inhibitors interact via hydrogen bonds near Cys320 without affecting NAD. A large flexible loop becomes ordered upon inhibitor binding, shielding the active site.\",\n      \"method\": \"X-ray crystallography, direct binding studies\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures with mechanistic interpretation; direct binding studies; single lab but multiple inhibitor chemotypes and rigorous structural analysis\",\n      \"pmids\": [\"29240402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mutations Ala151Ser and Ile157Thr in the ALDH1A2 tetramerization domain (exon 4) found in Tetralogy of Fallot patients were shown by molecular mechanics simulation to hinder tetramerization of the enzyme, suggesting loss of functional oligomeric assembly as a disease mechanism.\",\n      \"method\": \"Sequencing of CHD patients, molecular mechanics simulation (AMBER 9), phylogenetic conservation analysis\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational modeling only, no direct biochemical validation of impaired tetramerization in vitro\",\n      \"pmids\": [\"19886994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GM-CSF-induced RALDH2 expression in dendritic cells requires cooperative binding of the transcription factor Sp1 (activated via ERK and p38 MAPK) and the RAR/RXR complex (specifically RARα/RXRα) to the Aldh1a2 promoter; Sp1 binds GC-rich sites and RAR/RXR binds an RA response element (RARE) half-site near the TATA box. Inhibition of either Sp1 or RAR blocked GM-CSF-induced Aldh1a2 expression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), promoter-reporter luciferase assay, EMSA, pharmacological inhibitors, siRNA knockdown\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (ChIP, EMSA, luciferase, siRNA) in single lab establishing direct promoter mechanism\",\n      \"pmids\": [\"24788806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Notch signaling (via RBPJ) directly regulates Aldh1a2 transcription in dendritic cells; RBPJ protein binds the Aldh1a2 promoter and its deficiency reduces RALDH2 expression, shifting DC function from iTreg induction toward Th17 promotion. Overexpression of Aldh1a2 in RBPJ-deficient DCs rescued iTreg-promoting ability.\",\n      \"method\": \"DC-specific Rbpj knockout mice, ChIP, Aldh1a2 overexpression rescue, in vivo colitis model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct promoter binding, genetic KO with rescue, functional in vivo validation\",\n      \"pmids\": [\"28779023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PU.1 and IRF4 are transcriptional activators of the Aldh1a2 gene in dendritic cells; they form a heterodimer that binds an EICE motif at −1961/−1952 of the Aldh1a2 promoter. Knockdown of Spi1 (PU.1) or Irf4 reduced Aldh1a2 mRNA and RALDH2 enzyme activity; this binding was validated in freshly isolated splenic and mesenteric DCs.\",\n      \"method\": \"ChIP, reporter assay, EMSA, siRNA knockdown in BMDCs and primary DCs\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (ChIP, EMSA, reporter, siRNA) in vitro and ex vivo\",\n      \"pmids\": [\"30413670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RALDH2 is a required component of PPARγ-directed all-trans retinoic acid (ATRA) synthesis in dendritic cells; RDH10, RALDH2, and CRABP2 form a linear pathway downstream of PPARγ activation for ATRA production. Only DC subsets expressing all three proteins produce ATRA efficiently.\",\n      \"method\": \"Gene expression analysis, PPARγ activation, functional ATRA production assay in DC subsets\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional pathway validation in specific DC subsets, multiple proteins tested, single lab\",\n      \"pmids\": [\"23833249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Tbx5 transcription factor directly maintains aldh1a2 expression in foregut lateral plate mesoderm via an evolutionarily conserved intronic enhancer, establishing a Tbx5→Aldh1a2→RA→Shh→Wnt signaling cascade coordinating cardiopulmonary development. This was demonstrated in both Xenopus and mouse embryos.\",\n      \"method\": \"Xenopus and mouse embryo experiments, enhancer reporter assays, genetic epistasis, in situ hybridization\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct enhancer validation, two model organisms, genetic epistasis establishing pathway order\",\n      \"pmids\": [\"34643182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Foxc1a transcription factor directly binds the aldh1a2 promoter and restricts its expression in paraxial mesoderm; in foxc1a knockout zebrafish, aldh1a2 expression is significantly increased, elevating RA levels and reducing myod1 expression by suppressing fgf8a and deltaC. Knockdown of aldh1a2 in foxc1a nulls partially rescues myod1 expression.\",\n      \"method\": \"TALEN-mediated foxc1a knockout zebrafish, chromatin immunoprecipitation (ChIP) on zebrafish embryos, aldh1a2 morpholino knockdown, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP directly demonstrating foxc1a binding to aldh1a2 promoter, genetic null with epistasis rescue experiments\",\n      \"pmids\": [\"25724646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HOXA13 directly regulates Aldh1a2 expression by binding a conserved cis-regulatory element in the Aldh1a2 locus; in Hoxa13 mutant mice, Aldh1a2 expression, RA signaling, and interdigital programmed cell death are reduced. Maternal RA supplementation partially rescues digit separation defects.\",\n      \"method\": \"Hoxa13 knockout mice, ChIP (HOXA13 binding to Aldh1a2 locus), RA reporter, maternal RA rescue\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct cis-regulatory binding, genetic null with RA rescue\",\n      \"pmids\": [\"23553814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Wnt/β-catenin signaling directly represses ALDH1A2 expression in fetal kidney (WiT49) cells; β-catenin is recruited to the ALDH1A2 promoter and intron 1 (intron1G enhancer element) as shown by ChIP, and luciferase assays confirmed these elements mediate repression. Ectopic Wnt1, Wnt3a, Wnt4, and Wnt9b all repressed ALDH1A2, and this effect required β-catenin.\",\n      \"method\": \"ChIP, luciferase reporter assay, Wnt overexpression, β-catenin inhibition, immunohistochemistry in rat kidney\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (ChIP, luciferase, genetic, IHC), single lab\",\n      \"pmids\": [\"32258025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Aldh1a2 is the primary aldehyde dehydrogenase acting during pancreas development in zebrafish; a null allele (glycine-to-arginine change in the catalytic domain) produces a similar but less severe phenotype than the DEAB inhibitor treatment, revealing that maternal Aldh1a2 activity persists in zygotic null embryos. Translation-blocking (but not splice-blocking) morpholinos phenocopy DEAB treatment, confirming maternal protein contribution.\",\n      \"method\": \"Zebrafish forward genetics, morpholino knockdown, DEAB pharmacological inhibition, gene expression analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple approaches (null mutant, morpholino, inhibitor) establishing Aldh1a2 as primary enzyme with maternal contribution\",\n      \"pmids\": [\"20011517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Comparative regeneration analysis identified raldh2 as one of the most highly induced genes across adult caudal fin, adult heart, and larval fin regeneration in zebrafish; loss-of-function studies showed raldh2 expression is critical for wound epithelium and blastema formation. raldh2 expression during regeneration is regulated by Wnt and FGF/ERK signaling.\",\n      \"method\": \"Comparative microarray, in situ hybridization, functional loss-of-function studies in zebrafish regeneration model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional studies in three regeneration platforms with signaling pathway placement, single lab\",\n      \"pmids\": [\"19801676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RALDH2 is the predominant retinaldehyde dehydrogenase in the chick choroid (>100-fold higher than RALDH3) and is upregulated during recovery from form-deprivation myopia, leading to increased all-trans retinoic acid synthesis. Choroid conditioned medium from recovering eyes inhibited scleral proteoglycan synthesis, suggesting RALDH2-derived RA acts as a signal for ocular growth regulation.\",\n      \"method\": \"qRT-PCR, in situ hybridization, immunohistochemistry, LC-tandem MS quantification of atRA in organ cultures, (35)SO4 incorporation assay\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct enzyme identification with quantitative RA measurement and functional scleral assay, single lab\",\n      \"pmids\": [\"22323456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Global deletion of Aldh1a1 and Aldh1a2 in mice blocks spermatogenesis without affecting viability. Cell-specific deletion showed that RALDH2 synthesis of RA in Sertoli cells (but not germ cells) is required for the initial round of spermatogonial differentiation. ALDH1A3 activity cannot compensate for loss of both ALDH1A1 and ALDH1A2.\",\n      \"method\": \"Global and cell-specific (Sertoli cell and germ cell) Cre-loxP conditional knockout mice, histological analysis of spermatogenesis\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific genetic ablation with defined cellular phenotype and negative result for compensation by ALDH1A3\",\n      \"pmids\": [\"35574006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Biallelic hypomorphic missense variants in ALDH1A2 in two unrelated human families cause a lethal multiple congenital anomaly syndrome (diaphragmatic, pulmonary, cardiovascular defects). In vitro studies of the variants showed reduced RA production, and in silico modeling indicated probable impairment of ALDH1A2 function for three of four substitutions.\",\n      \"method\": \"Exome sequencing, in vitro RA synthesis assay, in silico protein modeling\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro functional validation of RA reduction, but structural modeling is computational; two independent families strengthen human disease link\",\n      \"pmids\": [\"33565183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In intestinal CD11b−CD103+ dendritic cells, CD137 engagement activates TAK1 and the AMPK-PGC-1α axis, which enhances Aldh1a2 transcription and RALDH2 expression. RALDH2-derived RA then acts on adjacent CD11b+CD103− DCs to induce SOCS3, suppressing p38MAPK and IL-23 production, defining a paracrine immunoregulatory circuit.\",\n      \"method\": \"DC-specific CD137 knockout mice, pathway inhibitors, RA administration rescue, gene expression analysis, in vivo colitis model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with pathway dissection and rescue, single lab\",\n      \"pmids\": [\"32209473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ALDH1A2 depletion by RNA interference in primary human chondrocytes altered expression of chondrogenic markers including SOX9, establishing a functional role for ALDH1A2 in chondrocyte biology. The OA-risk allele rs12915901 is associated with reduced ALDH1A2 expression in cartilage through allelic expression imbalance, with Ets transcription factors identified as potential mediators.\",\n      \"method\": \"RNAi knockdown in primary human chondrocytes, allelic expression imbalance by pyrosequencing, in silico and in vitro analysis of SNP function\",\n      \"journal\": \"Arthritis & rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi knockdown with gene expression phenotype, allelic imbalance confirmed in patient tissues, single lab\",\n      \"pmids\": [\"29732726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cartilage injury upregulates inflammatory genes (mechanoflammation) with concomitant reduction of atRA-inducible genes; talarozole (a RAMBA that blocks RA catabolism, thereby boosting atRA) reverses both responses via a PPARγ-dependent mechanism. Talarozole suppressed mechano-inflammatory genes in articular cartilage in vivo 6 hours after joint destabilization and reduced cartilage degradation and osteophyte formation after 26 days in mice.\",\n      \"method\": \"RNA sequencing of human OA cartilage stratified by genotype, cartilage injury model, talarozole treatment in vitro and in vivo, PPARγ pathway analysis\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human tissue stratified by genotype + in vitro mechanism + in vivo mouse validation with defined pathway (PPARγ)\",\n      \"pmids\": [\"36542696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Aldh1a2+ fibroblastic reticular cells (FRCs) in omental milky spots regulate lymphocyte recruitment by controlling CXCL12 display on high endothelial venules (HEVs). Diphtheria toxin-mediated ablation of Aldh1a2+ FRCs reduced milky spot size and cellularity and altered peritoneal lymphocyte composition.\",\n      \"method\": \"Cell-specific diphtheria toxin ablation (Aldh1a2-DTR mouse), flow cytometry, immunofluorescence, CXCL12 expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — selective cell ablation with mechanistic link to CXCL12/HEV pathway, single lab\",\n      \"pmids\": [\"36880532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"GM-CSF-IL-4-induced differentiating dendritic cells express ALDH1A2 and produce retinoic acid that inhibits DC maturation (autocrine brake). Genetic knockout of Aldh1a2 in DCs enhances DC function and antigen-specific T cell responses. A selective ALDH1A2 small-molecule inhibitor with high potency was developed and shown to improve DC vaccine efficacy.\",\n      \"method\": \"Genetic Aldh1a2 knockout in DCs, ALDH1A2 inhibitor development and testing, DC vaccine efficacy assays, antigen-specific T cell response measurement\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO + pharmacological inhibitor with orthogonal functional readouts establishing autocrine RA-mediated brake on DC maturation\",\n      \"pmids\": [\"41491403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Identification and characterization by mass spectrometry of a WIN18,446 aldehyde metabolite (M-54) and a WIN18,446-derived protein adduct of mass 292.07 Da on Cys319 of ALDH1A2, confirming covalent modification of the active-site cysteine as the mechanism of irreversible inhibition. Analogous adducts were detected on ALDH1A1 and ALDH2 active-site cysteines in human liver samples.\",\n      \"method\": \"Mass spectrometry (proteomics), crystal structure, LC-MS/MS, human liver samples\",\n      \"journal\": \"Drug metabolism reviews\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus MS-based direct identification of covalent adduct, mechanistic extension of prior structural work\",\n      \"pmids\": [\"42124481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"First apo-ALDH1A2 crystal structure (without bound ligand/cofactor) was obtained from nanolitre sitting-drop crystallisation, expanding the structural basis for drug discovery studies on this isoform.\",\n      \"method\": \"X-ray crystallography (nanolitre sitting-drop crystallisation)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — structural determination is rigorous but no functional mutagenesis or binding studies reported in abstract\",\n      \"pmids\": [\"40829477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Cardiomyocyte-specific ALDH1A2 ablation aggravated heart dysfunction and fibrosis after ischemia-reperfusion injury in mice, whereas ALDH1A2 overexpression provided protection. The cardioprotective mechanism depends on ALDH1A2-catalyzed RA production, which activates RA receptors to regulate Bmp7 transcription, inhibiting cell death and cardiac fibrosis.\",\n      \"method\": \"Cardiomyocyte-specific Aldh1a2 knockout and overexpression in mouse I/R model, transcriptional profiling, RA receptor pathway analysis, Bmp7 expression measurement\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic gain- and loss-of-function in vivo with defined RA→RAR→Bmp7 pathway, single lab\",\n      \"pmids\": [\"41689430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RALDH2 mRNA is a direct post-transcriptional target of the RNA-binding protein tristetraprolin (TTP/ZFP36) in intestinal dendritic cells; Zfp36−/− mice show increased vitamin A metabolism by gut DCs and expanded colonic Treg numbers, a phenotype linked to elevated RALDH2 activity.\",\n      \"method\": \"Zfp36 knockout mice, colonic DC analysis, vitamin A metabolism assay, Treg quantification\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with direct statement of RALDH2 as TTP target and functional Treg readout, single lab\",\n      \"pmids\": [\"32467605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ROBO2 binds RALDH2 as a novel binding partner in the common nephric duct (CND) and primitive bladder; loss of Robo2 impairs CND migration and fusion with the primitive bladder, delayed apoptosis, and abnormal ureter connection. Retinoic acid administration rescued ureter anomalies in Robo2−/− embryos, establishing a ROBO2-RALDH2-RA pathway in ureter development.\",\n      \"method\": \"Robo2 knockout mice, Co-IP (ROBO2-RALDH2 interaction), in situ hybridization, RA rescue experiment\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — binding partner identification by Co-IP, genetic null with RA rescue, single lab\",\n      \"pmids\": [\"32562756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Non-canonical NF-κB signaling (RelB:p52) in intestinal DCs activates Axin1 transcription, thereby destabilizing β-catenin and reducing β-catenin-dependent Raldh2 expression, which suppresses tolerogenic DC function. DC-specific inactivation of non-canonical NF-κB signaling reinforces β-catenin→Raldh2 axis and increases colonic Tregs and IgA+ B cells. β-catenin haploinsufficiency in DCs lacking non-canonical NF-κB reinstates colitogenic sensitivity.\",\n      \"method\": \"DC-specific RelB knockout mice, β-catenin haploinsufficiency mouse model, genetic epistasis, transcription analysis, colitis model\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic models establishing pathway order (RelB:p52→Axin1→β-catenin→Raldh2), epistasis rescue experiment, single lab\",\n      \"pmids\": [\"39060515\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ALDH1A2 (RALDH2) is a NAD+-dependent aldehyde dehydrogenase that catalyzes the irreversible oxidation of retinaldehyde to all-trans retinoic acid (RA) via its active-site Cys320; it functions as a homotetramer, operates with highest catalytic efficiency for all-trans retinal, and acts as the principal embryonic RA-synthesizing enzyme in trunk mesoderm, where it generates a diffusible RA signal that patterns the nervous system, heart, pharyngeal arches, pancreas, limbs, and other organs through non-cell-autonomous mechanisms; in adult tissues it controls spermatogonial differentiation (from Sertoli cells), ocular growth, fin/heart regeneration, DC-mediated tolerogenic immune responses (regulated at the transcriptional level by WT1, Wt1/RBPJ-Notch, PU.1/IRF4, Tbx5, HOXA13, Foxc1a, and Wnt/β-catenin signaling, and post-transcriptionally by tristetraprolin), and cartilage homeostasis via suppression of mechanoflammation through a PPARγ-dependent pathway; its activity is irreversibly inhibited by covalent modification of Cys320 (e.g., by WIN18,446), and loss of enzymatic activity—whether by gene deletion, hypomorphic variants, or epigenetic silencing—underlies diverse human pathologies including congenital heart and diaphragmatic defects, osteoarthritis, and multiple cancers.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ALDH1A2 (RALDH2) is the principal embryonic retinoic acid (RA)-synthesizing enzyme, an NAD+-dependent retinaldehyde dehydrogenase that catalyzes oxidation of retinal to all-trans RA with highest catalytic efficiency for all-trans retinal [#1, #2], generating a diffusible RA signal that patterns multiple developing organs [#0, #3]. Its catalytic mechanism centers on an active-site cysteine (Cys320/Cys319), which irreversible inhibitors such as WIN18,446 covalently modify, distorting the bound NAD cofactor and abolishing dehydrogenase activity [#13, #33]. Genetic ablation eliminates nearly all embryonic RA synthesis and arrests development at midgestation [#3], and RALDH2-derived mesodermal RA acts non-cell-autonomously to control posterior neural transformation, pharyngeal and enteric patterning, dorsal pancreatic budding, optic cup formation, limb initiation, and cardiopulmonary morphogenesis [#4, #5, #6, #7, #8, #9, #19]. Its enzymatic, RA-producing function is required for its biological output, as shown by loss of activity in catalytically dead variants [#10]. Expression is controlled by a wide regulatory network including WT1 in epicardium, Tbx5, HOXA13, and Foxc1a in developing mesoderm, Wnt/\\u03b2-catenin repression, and—in dendritic cells—Sp1/RAR\\u2013RXR, RBPJ\\u2013Notch, and PU.1/IRF4, plus post-transcriptional control by tristetraprolin [#12, #19, #20, #21, #22, #15, #16, #17, #36]. In adult physiology, RALDH2-derived RA drives spermatogonial differentiation from Sertoli cells [#26], tolerogenic dendritic-cell programs that favor Treg induction [#16, #28, #38], cardiac protection after ischemia\\u2013reperfusion via RA\\u2192RAR\\u2192Bmp7 signaling [#35], and cartilage homeostasis through a PPAR\\u03b3-dependent suppression of mechanoflammation [#30]. Biallelic hypomorphic ALDH1A2 variants that reduce RA production cause a lethal multiple congenital anomaly syndrome with diaphragmatic, pulmonary, and cardiovascular defects [#27], and reduced cartilage expression is linked to osteoarthritis risk [#29].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established the enzymatic identity of RALDH2 as a major embryonic RA-generating enzyme and revealed RA-dependent negative feedback on its own expression.\",\n      \"evidence\": \"In situ hybridization and RA administration in mouse embryos\",\n      \"pmids\": [\"9106168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not provide direct biochemical kinetics\", \"Feedback mechanism at transcriptional level not molecularly dissected\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated in vivo that Raldh2 genuinely synthesizes RA and localized the protein to trunk mesodermal tissues, distinguishing it from non-RA-producing aldehyde dehydrogenases.\",\n      \"evidence\": \"Xenopus mRNA injection RA assay and whole-mount immunohistochemistry in mouse\",\n      \"pmids\": [\"10570467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish substrate kinetics\", \"Did not test requirement by loss-of-function\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the biochemical parameters of catalysis, confirming retinal oxidation with substrate preference and inhibitor/activator sensitivity.\",\n      \"evidence\": \"In vitro kinetics with purified recombinant mouse RALDH2\",\n      \"pmids\": [\"11983430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic residue not yet mapped structurally\", \"Oligomeric state not directly resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetic null established RALDH2 as responsible for nearly all embryonic RA synthesis and revealed residual non-Raldh1-3 RA activity in neural tube and heart.\",\n      \"evidence\": \"Raldh2 knockout mice with RA-reporter transgene and maternal RA rescue\",\n      \"pmids\": [\"11959834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of residual RA-generating activity unresolved\", \"Tissue-specific contributions not separated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed mesoderm-derived RALDH2 RA acts non-cell-autonomously on adjacent neural tissue, defining the signaling logic of RALDH2 patterning.\",\n      \"evidence\": \"Zebrafish neckless forward genetics, mosaic analysis, RA rescue\",\n      \"pmids\": [\"11688558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RA receptor effectors in neural tissue not defined here\", \"Quantitative gradient not measured\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapped organ-specific RALDH2 functions across pharyngeal, pancreatic, ocular, limb, and neural development, establishing it as a master source of patterning RA.\",\n      \"evidence\": \"Raldh2 knockout/conditional-rescue mice with RA reporters and maternal RA rescue across multiple organ systems\",\n      \"pmids\": [\"12702665\", \"16026781\", \"15366004\", \"15069081\", \"15652703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets of RA differ per organ and remain partial\", \"Timing thresholds not fully defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Linked ALDH1A2 enzymatic activity to tumor-suppressive function, showing the RA-synthesizing activity is required for growth suppression.\",\n      \"evidence\": \"Wild-type vs. catalytic mutant re-expression in DU145 prostate cancer cells, colony assay\",\n      \"pmids\": [\"16166285\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Catalytic mutant only minimally characterized\", \"Single cell line, mechanism downstream of RA not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed context-dependent pro-tumor effects of ALDH1A2 overexpression and clarified Aldefluor/DEAB assay specificity across ALDH isoforms.\",\n      \"evidence\": \"Lentiviral overexpression, Aldefluor flow cytometry, DEAB inhibition in K562/H1299 cells\",\n      \"pmids\": [\"22079344\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Opposite to tumor-suppressive role elsewhere; context determinants unknown\", \"Single lab, drug-resistance mechanism not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified WT1 as a direct transcriptional activator linking epicardial cell identity to RALDH2-driven RA synthesis and PDGFR\\u03b1 expression.\",\n      \"evidence\": \"Wt1-null epicardial cells, RA reporter, transcriptional target analysis, rescue\",\n      \"pmids\": [\"21343363\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter binding inferred rather than fully mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the structural basis of catalysis and inhibition, showing WIN18,446 covalently modifies Cys320 and distorts NAD into a catalytically incompetent conformation.\",\n      \"evidence\": \"X-ray crystallography of human ALDH1A2 with multiple inhibitor chemotypes\",\n      \"pmids\": [\"29240402\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Apo and fully catalytic states resolved only later\", \"Substrate-bound Michaelis complex not captured\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established direct human disease causation: biallelic hypomorphic variants reducing RA production cause a lethal multiple congenital anomaly syndrome.\",\n      \"evidence\": \"Exome sequencing in two families, in vitro RA synthesis assays, in silico modeling\",\n      \"pmids\": [\"33565183\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural impact partly computational\", \"Genotype-phenotype range not fully defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined an upstream transcriptional cascade in which Tbx5 maintains aldh1a2 via a conserved intronic enhancer to coordinate cardiopulmonary development.\",\n      \"evidence\": \"Xenopus and mouse enhancer reporters, genetic epistasis, in situ hybridization\",\n      \"pmids\": [\"34643182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other enhancer inputs in non-cardiac tissues not characterized\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Dissected the dendritic-cell transcriptional control of RALDH2, identifying cooperative Sp1/RAR-RXR, RBPJ-Notch, and PU.1/IRF4 inputs plus PPAR\\u03b3-directed pathway assembly governing tolerogenic RA production.\",\n      \"evidence\": \"ChIP, EMSA, reporter assays, siRNA, DC-specific knockouts, pathway reconstitution in DC subsets\",\n      \"pmids\": [\"24788806\", \"28779023\", \"30413670\", \"23833249\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Combinatorial integration of these inputs not fully reconstituted\", \"Mostly mouse DC systems\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapped repressive and restrictive transcriptional regulators (Foxc1a, HOXA13, Wnt/\\u03b2-catenin) that spatially bound and tune aldh1a2 expression in developing tissues.\",\n      \"evidence\": \"ChIP, genetic nulls/epistasis, luciferase reporters in zebrafish, mouse, and kidney cells\",\n      \"pmids\": [\"25724646\", \"23553814\", \"32258025\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cross-talk among activators and repressors at the locus not integrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated cell-type-specific adult requirement: Sertoli-cell RALDH2-derived RA drives the initial round of spermatogonial differentiation, non-redundant with ALDH1A3.\",\n      \"evidence\": \"Global and cell-specific Cre-loxP knockout mice, histology\",\n      \"pmids\": [\"35574006\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RA target genes in germ cells not fully defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established a cartilage-protective role through PPAR\\u03b3-dependent suppression of mechanoflammation, linking reduced ALDH1A2/RA to osteoarthritis.\",\n      \"evidence\": \"RNA-seq of genotype-stratified human OA cartilage, talarozole treatment in vitro and in mouse joint-injury models, RNAi in chondrocytes\",\n      \"pmids\": [\"36542696\", \"29732726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct enzyme-PPAR\\u03b3 mechanistic coupling not fully resolved\", \"Therapeutic translation unproven\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Expanded the regulatory and physiological repertoire to post-transcriptional control (TTP), a ROBO2 binding partner in ureter development, regeneration, ocular growth, milky-spot stroma, and paracrine immune circuits.\",\n      \"evidence\": \"Zfp36 knockout, Co-IP with ROBO2 and RA rescue, zebrafish regeneration, chick choroid RA quantification, cell ablation, DC pathway dissection\",\n      \"pmids\": [\"32467605\", \"32562756\", \"19801676\", \"22323456\", \"36880532\", \"32209473\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ROBO2-RALDH2 interaction is single Co-IP without reciprocal validation\", \"Several roles are single-lab functional associations\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Defined an autocrine RA brake on DC maturation and a cardioprotective RA\\u2192RAR\\u2192Bmp7 axis, and developed selective inhibitors enabling therapeutic targeting.\",\n      \"evidence\": \"Aldh1a2 DC and cardiomyocyte conditional knockouts/overexpression, small-molecule inhibitors, DC vaccine and I/R injury assays\",\n      \"pmids\": [\"41491403\", \"41689430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Inhibitor selectivity over ALDH1A1/ALDH2 in vivo not fully resolved\", \"Bmp7 regulation mechanism partial\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended structural and mechanistic understanding with the apo structure and direct mass-spectrometric confirmation of the Cys319 covalent adduct underlying irreversible inhibition.\",\n      \"evidence\": \"Apo X-ray structure, LC-MS/MS adduct identification in human liver\",\n      \"pmids\": [\"40829477\", \"42124481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional mutagenesis of apo structure reported\", \"Isoform-selective targeting still limited by shared catalytic cysteine\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse activating and repressing transcription factors are combinatorially integrated at the ALDH1A2 locus to produce spatially precise RA gradients, and how RALDH2 inhibition can be made isoform-selective given the shared active-site cysteine, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of cis-regulatory integration\", \"No isoform-selective covalent inhibitor mechanism established\", \"RA receptor effector logic differs across tissues\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [1, 2, 13, 33]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4, 5, 6, 7, 8, 9, 19]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [15, 16, 17, 28, 38]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 9, 35]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ROBO2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}